COVID-19 patients (N = 1,099) were spliced into groups based upon their AST and ALT levels and majority of them occurred in severe and catastrophic cases, with 39.4% having AST level greater than 40 U/L and 28.1% having ALT level greater than 40 U/L (58). This evidence concerns the gene GPT and COVID-19.